RESUMO
An unmet medical need remains for patients suffering from dry eye disease (DED). A fast-acting, better-tolerated noncorticosteroid anti-inflammatory eye drop could improve patient outcomes and quality of life. Herein, we describe a small-molecule drug discovery effort to identify novel, potent, and water-soluble JAK inhibitors as immunomodulating agents for topical ocular disposition. A focused library of known 3-(4-(2-(arylamino)pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitriles was evaluated as a molecular starting point. Structure-activity relationships (SARs) revealed a ligand-efficient (LE) JAK inhibitor series, amenable to aqueous solubility. Subsequent in vitro analysis indicated the potential for off-target toxicity. A KINOMEscan selectivity profile of 5 substantiated the likelihood of widespread series affinity across the human kinome. An sp2-to-sp3 drug design strategy was undertaken to attenuate off-target kinase activity while driving JAK-STAT potency and aqueous solubility. Tactics to reduce aromatic character, increase fraction sp3 (Fsp3), and bolster molecular complexity led to the azetidin-3-amino bridging scaffold in 31.
Assuntos
Inibidores de Janus Quinases , Humanos , Janus Quinase 1 , Janus Quinase 2 , Janus Quinase 3 , Inibidores de Janus Quinases/farmacologia , Janus Quinases , Fosforilação , Inibidores de Proteínas Quinases/farmacologia , SolubilidadeRESUMO
A new drug delivery strategy was investigated for the development of potent anti-parasitic compounds against Trypanosoma brucei, the causative agent of African sleeping sickness. Thus, potent in vitro hexokinase inhibitors were rendered cytotoxic by appending a tripeptide peroxosomal targeting sequence that facilitated delivery of the molecular cargo to the appropriate organelle in the parasite.
RESUMO
Human African trypanosomiasis is a disease of sub-Saharan Africa, where millions are at risk for the illness. The disease, commonly referred to as African sleeping sickness, is caused by an infection by the eukaryotic pathogen, Trypanosoma brucei. Previously, a target-based high throughput screen revealed ebselen (EbSe), and its sulfur analog, EbS, to be potent in vitro inhibitors of the T. brucei hexokinase 1 (TbHK1). These molecules also exhibited potent trypanocidal activity in vivo. In this manuscript, we synthesized a series of sixteen EbSe and EbS derivatives bearing electron-withdrawing carboxylic acid and methyl ester functional groups, and evaluated the influence of these substituents on the biological efficacy of the parent scaffold. With the exception of one methyl ester derivative, these modifications ablated or blunted the potent TbHK1 inhibition of the parent scaffold. Nonetheless, a few of the methyl ester derivatives still exhibited trypanocidal effects with single-digit micromolar or high nanomolar EC50 values.
Assuntos
Antiprotozoários/farmacologia , Azóis/farmacologia , Compostos Organosselênicos/farmacologia , Tripanossomicidas/farmacologia , Trypanosoma brucei brucei/efeitos dos fármacos , Antiprotozoários/síntese química , Antiprotozoários/química , Azóis/síntese química , Azóis/química , Relação Dose-Resposta a Droga , Isoindóis , Estrutura Molecular , Compostos Organosselênicos/síntese química , Compostos Organosselênicos/química , Testes de Sensibilidade Parasitária , Relação Estrutura-Atividade , Tripanossomicidas/síntese química , Tripanossomicidas/químicaRESUMO
OBJECTIVE: Fatigue, mood disturbances and cognitive dysfunction are frequent in patients infected with hepatitis C virus (HCV) who have mild liver disease. The reason is still unclear. The present study aims to gain more insight into the pathomechanism by combining an extensive neuropsychological examination with magnetic resonance spectroscopy in four different brain regions in a patient group covering the whole spectrum of neuropsychiatric findings in patients afflicted with HCV who have only mild liver disease. METHODS: 53 HCV-positive patients with only mild liver disease and differing degrees of neuropsychiatric symptoms were studied with single-voxel MRS of the parietal white matter, occipital grey matter, basal ganglia and pons. Brain metabolite concentrations were quantitatively analysed by using LCmodel. MRS data were compared to those of 23 healthy controls adjusted for age, and analysed for relationships with the extent of neuropsychiatric symptoms. RESULTS: Choline (p=0.02), creatine (p=0.047) and N-acetyl-aspartate plus N-acetyl-aspartyl-glutamate (NN, p=0.02) concentrations in the basal ganglia and choline concentrations in the white matter (p=0.045) were significantly higher in the patients than in controls. Interestingly, the difference was most evident for the patients with low fatigue scores (eg, white matter: choline: p=0.001, creatine: p=0.003, NN: p=0.031). Myo-inositol differed significantly between groups in the white (p=0.001) and grey matter (p=0.003). Fatigue correlated negatively with white matter NN, choline and creatine and myo-inositol levels in white and grey matter and basal ganglia (p<0.01). CONCLUSION: As the increase of choline, creatine and myo-inositol are usually interpreted to indicate glial activation and macrophage infiltration in chronic inflammation and slow virus infections of the brain the present data endorse the hypothesis, that HCV infection may induce neuroinflammation and brain dysfunction. The concomitant increase of NN and the negative correlation to the extent of fatigue suggest a cerebral compensatory process after HCV infection.
Assuntos
Encefalopatia Hepática/virologia , Hepatite C/complicações , Adulto , Idoso , Ácido Aspártico/análogos & derivados , Ácido Aspártico/metabolismo , Encéfalo/metabolismo , Mapeamento Encefálico/métodos , Estudos de Casos e Controles , Colina/metabolismo , Transtornos Cognitivos/metabolismo , Transtornos Cognitivos/virologia , Creatina/metabolismo , Dipeptídeos/metabolismo , Fadiga/metabolismo , Fadiga/virologia , Feminino , Encefalopatia Hepática/metabolismo , Hepatite C/metabolismo , Humanos , Inositol/metabolismo , Espectroscopia de Ressonância Magnética/métodos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Psicometria , Índice de Gravidade de DoençaRESUMO
Aneurysms of the portal venous system are increasingly reported in the past five years. Congenital weakness of the venous wall, trauma, pancreatitis and portal hypertension are possible etiologies. Surgical intervention is indicated in case of symptomatic aneurysms with or without progressive expansion of the aneurysm diameter. The treatment of asymptomatic splenic vein aneurysms remains debated. We report the case of an asymptomatic and uncomplicated splenic vein aneurysm for which a conservative approach was advocated with regular follow-up by means of Doppler ultrasonography. After six years of follow-up the aneurysm diameter has not changed and no complications were observed.
Assuntos
Aneurisma , Veia Esplênica , Adulto , Aneurisma/diagnóstico , Aneurisma/terapia , Feminino , HumanosRESUMO
This report examines the reliability of nighttime blood pressure dipping. Twenty-one individuals were studied twice with ambulatory blood pressure monitoring. On one occasion they were studied as outpatients, and on the other as inpatients on a clinical research ward. Blood pressure monitoring revealed the expected dip in blood pressure at nighttime. However, there was little test-retest reliability across the two settings. The test-retest correlations for the dip in blood pressure across the two settings were nonsignificant for systolic, diastolic, and mean arterial blood pressure. Caution is advised before diagnosing dipping or nondipping on the basis of one 24-h ambulatory blood pressure recording.
Assuntos
Pressão Sanguínea/fisiologia , Ritmo Circadiano/fisiologia , Adulto , Monitorização Ambulatorial da Pressão Arterial , Fenômenos Cronobiológicos/fisiologia , Diástole , Feminino , Humanos , Pacientes Internados , Masculino , Pacientes Ambulatoriais , SístoleRESUMO
The assay of different penicillins in the European Pharmacopoeia was carried out by mercurimetric titration with potentiometric determination of the end-point. The consecutive formation of reaction products during titration was followed by reversed-phase liquid chromatography (LC) and ultraviolet detection. In one experiment the titration was carried out with 14C-labeled benzylpenicillin and the reaction was followed with LC coupled to radiochemical detection. The identity of the intermediates and final reaction products was deduced from their retention times in comparison with reference products obtained by independent chemical transformation of benzylpenicillin. This allowed one to define for the first time the complete reaction scheme. This involves the isomerization of the natural penicilloic acid followed by decarboxylation, which has not been reported previously. At the end of the titration, only benzylpenilloaldehyde and a 1:1 complex of mercury and penicillamine were present in the solution.
Assuntos
Penicilina G/análise , Penicilinas/análise , Cromatografia Líquida , Descarboxilação , Hidrólise , Indicadores e Reagentes , Espectroscopia de Ressonância Magnética , Compostos de Mercúrio , Nitratos , Penicilamina/química , Penicilina G/análogos & derivados , Penicilina G/química , Potenciometria , Espectrofotometria Ultravioleta , Estereoisomerismo , TitulometriaRESUMO
GABAA receptors were characterized in cellular fractions isolated from adult bovine brain. The fraction enriched in cortical astrocytes is very rich in high-affinity binding sites for [3H]flunitrazepam and other "central-type" benzodiazepine ligands. The amount of specific [3H]flunitrazepam binding was more than five times higher in the glial fraction than in synaptosomal and perikaryal fractions. [3H]Flunitrazepam was displaced by low concentrations of clonazepam and other specific ligands for central GABAA receptors. Specific binding sites for GABA, flunitrazepam, barbiturates, and picrotoxin-like convulsants were characterized. Allosteric interactions between the different sites were typical of central-type GABAA receptors. The presence of alpha-subunit(s), as revealed by [3H]flunitrazepam photoaffinity labeling, was demonstrated in all brain fractions at molecular mas 51-53 kDa. Photoaffinity labeling was highest in the glial fraction. However, in primary cultured astrocytes from neonate rat cortex, no photoaffinity labeling was detected. Information obtained from astrocytes in culture should thus be taken with caution when extrapolated to differentiated astroglial cells. Our results actually show that, in mature brain, most of the fully pharmacologically active GABAA receptors are extrasynaptic and expressed in astroglia.
Assuntos
Envelhecimento/metabolismo , Astrócitos/metabolismo , Encéfalo/crescimento & desenvolvimento , Encéfalo/metabolismo , Receptores de GABA-A/metabolismo , Animais , Benzodiazepinas/metabolismo , Sítios de Ligação , Encéfalo/citologia , Bovinos , Células Cultivadas , Picrotoxina/metabolismo , Ratos , Ratos Wistar , Ácido gama-Aminobutírico/metabolismoRESUMO
A polypeptide of M(r) 36,000 (36 kDa) was isolated from detergent-solubilized membrane fractions of mammalian brain on a benzodiazepine affinity column utilized for the purification of the gamma-aminobutyric acid/benzodiazepine receptor protein, followed by preparative gel electrophoresis. Partial protein sequence for two fragments of the 36-kDa polypeptide allowed the isolation of cDNA clones from a rat hippocampal library. An open reading frame coding a sequence of 295 amino acid residues containing the two probe peptide sequences with minor differences, and a putative N-terminal signal peptide of 25 residues was found. Hydropathy index revealed no regions of alpha-helix suitable for membrane spanning, but several areas of alternating hydrophilic and hydrophobic residues consistent with beta-strands. The sequence of this brain protein was 24% identical to that of a yeast mitochondrial protein, the voltage-dependent anion channel (VDAC), and over 70% identical with the VDAC from human B lymphocytes. The gamma-aminobutyric acid type A (GABAA) receptor/36-kDa preparation purified on benzodiazepine affinity column has channel-forming activity in lipid bilayer membranes that is virtually identical to VDAC isolated from mitochondria of various sources, indicating that the 36-kDa protein is a new member of the VDAC family of proteins. An antiserum raised against the purified 36-kDa polypeptide was able to precipitate [3H]muscimol binding activity, indicating a tight association with the GABAA receptor protein in vitro and copurification on the benzodiazepine affinity column due to this association. Further studies are needed to determine whether such an association occurs in vivo.
Assuntos
Encéfalo/metabolismo , Canais Iônicos , Sequência de Aminoácidos , Animais , Ânions , Sequência de Bases , Western Blotting , Bovinos , Cromatografia de Afinidade , Clonagem Molecular , DNA/genética , Eletroforese em Gel de Poliacrilamida , Humanos , Dados de Sequência Molecular , Ratos , Receptores de GABA-A/metabolismoRESUMO
Antibody-capture enzyme-linked immunosorbent assays (AC-ELISA) which use enzyme-labelled antigen were developed for detection of varicella-zoster virus-(VZV) specific IgM, IgA and IgG antibody in patients with varicella or herpes zoster and in sera from healthy individuals. All 18 patients with varicella developed a VZV-IgM and a VZV-IgG response, 17 also a VZV-IgA response. In contrast, all 19 patients with herpes zoster were shown to be positive for VZV-IgA whereas only 13 of these reacted positively for VZV-IgM. A VZV-IgM response was detected in only two sera from 100 healthy individuals and an IgA response in only one. The presence of virus-specific IgA and IgG in the cerebrospinal fluid as determined by AC-ELISA was a useful indicator of VZV infection of the central nervous system. By AC-ELISA, VZV-IgG was detected predominantly in sera from patients with acute or recent VZV infection. Only 14 sera from 100 healthy individuals were positive for VZV-IgG by AC-ELISA, whereas all were positive by an indirect ELISA. These results indicate that AC-ELISA's may be useful assays for determination for acute or recurrent VZV infection, but are not suitable for determination of past infection with this virus.
Assuntos
Varicela/imunologia , Ensaio de Imunoadsorção Enzimática/normas , Herpes Zoster/imunologia , Herpesvirus Humano 3/imunologia , Imunoglobulinas/sangue , Doença Aguda , Anticorpos Antivirais/sangue , Relação Dose-Resposta Imunológica , Estudos de Avaliação como Assunto , Seguimentos , Humanos , Imunoglobulina A/sangue , Imunoglobulina A/líquido cefalorraquidiano , Imunoglobulina G/sangue , Imunoglobulina G/líquido cefalorraquidiano , Imunoglobulina M/sangue , Imunoglobulinas/líquido cefalorraquidiano , Meningoencefalite/imunologia , Valor Preditivo dos Testes , RecidivaRESUMO
Partially purified (Na+,K+)-ATPase (E.C. 3.6.1.3.) was investigated in the epileptic cortex of audiogenic DBA/2 mice and in the primary and secondary foci of cats with acute or chronic freeze lesions. No differences in specific activities measured at 3 mM K+ were observed between epileptic and control cortex, except an increase of enzymic activities in the primary focus of acutely lesioned cats. The (Na+,K+)-ATPase catalytic subunits were resolved by SDS-gel electrophoresis and their phosphorylation levels were measured in presence of K+ ions and phenytoin. K+ was more effective in inducing maximal dephosphorylation of (Na+,K+)-ATPase in C57/BL, with identical affinity in the two strains. Phenytoin decreased the net phosphorylation level of (Na+,K+)-ATPase by about 50% in C57/BL mice, but only by 20% in DBA/2 mice. Both K+ and phenytoin dephosphorylating influences were decreased in primary and secondary foci of acutely lesioned cats. Those changes were limited to the alpha(-) subunit. In chronic cats, the dephosphorylating step of the (Na+,K+)-ATPase catalytic subunit recovered a normal affinity to K+, but its sensitivity to phenytoin remained decreased. Those differences in K+ and phenytoin influences on brain (Na+,K+)-ATPases between control and epileptic cortex might be responsible for the ictal transformation and seizure spread. In cats, the alteration of the alpha(-) isoform could mainly affect the glial cells.
Assuntos
Encéfalo/enzimologia , Córtex Cerebral/metabolismo , Epilepsia/metabolismo , ATPase Trocadora de Sódio-Potássio/metabolismo , Estimulação Acústica , Animais , Catálise , Gatos , Eletroforese em Gel de Poliacrilamida , Congelamento , Camundongos , Camundongos Endogâmicos , Proteínas do Tecido Nervoso/metabolismo , Fenitoína/farmacologia , Fosforilação , Potássio/farmacologia , Valores de ReferênciaRESUMO
We examined the activity and phosphorylation level of (Na+,K+)-ATPase (E.C. 3.6.1.3) partially purified from normal and epileptic human cortices. Control patients (n = 11) were operated on for a non-epileptogenic deep brain lesion, while epileptic patients (n = 10) were operated on for temporal or frontal originating partial seizures, resistant to medications or secondary to evolutive brain tumors. No differences in the specific activity of microsomal (Na+,K+)-ATPase were observed between the two groups of patients. After partial purification of the enzyme followed by SDS-polyacrylamide gel electrophoresis, (Na+,K+)-ATPase catalytic subunit had a decreased affinity for K+ in human epileptic cortex and lost its sensitivity to phenytoin dephosphorylation. Indirect evidence suggests that those abnormalities of (Na+,K+)-ATPase in human epileptic cortex hold preferentially true for the alpha(-) enzymatic subunit. Those results indicate that, in human epileptic cortex, (Na+,K+)-ATPase and most probably its glial subtype is altered in its K+ regulation and phenytoin sensitivity and could be responsible for ictal transformation and seizure spread.
Assuntos
Encéfalo/enzimologia , Córtex Cerebral/enzimologia , Epilepsias Parciais/enzimologia , Epilepsia/enzimologia , ATPase Trocadora de Sódio-Potássio/metabolismo , Catálise , Eletroforese em Gel de Poliacrilamida , Humanos , Fenitoína/farmacologia , Fosforilação , Potássio/farmacologia , Valores de ReferênciaRESUMO
Analysis of purified Na+,K+-ATPase from cat and human cortex by sodium dodecyl sulfate-polyacrylamide gel electrophoresis reveals two large catalytic subunits called alpha (-) (lower molecular weight) and alpha (+) (higher molecular weight). Differences in K+ dephosphorylation of these two molecular forms have been investigated by measuring the phosphorylation level of each protein after their separation on sodium dodecyl sulfate gels. In the presence of Na+, Mg2+, and ATP, both subunits are phosphorylated. Increasing concentrations (from 0 to 3 mM) of K+ induce progressive dephosphorylation of both alpha-subunits, although the phosphoprotein content of alpha (-) is decreased significantly less than that of alpha (+). Ka values of alpha (-) for K+ are 40% and 50% greater in cat and human cortex, respectively, than values of alpha (+). alpha (-) and alpha (+) are thought to be localized in specific cell types of the brain: alpha (-) is the exclusive form of nonneuronal cells (astrocytes), whereas alpha (+) is the only form of axolemma. Our results support the hypothesis that glial and neuronal Na+,K+-ATPases are different molecular entities differing at least by their K+ sensitivity. Results are discussed in relation to the role of glial cells in the regulation of extracellular K+ in brain.
Assuntos
Córtex Cerebral/enzimologia , Isoenzimas/metabolismo , Potássio/farmacologia , ATPase Trocadora de Sódio-Potássio/metabolismo , Animais , Gatos , Eletroforese Descontínua , Humanos , Isoenzimas/isolamento & purificação , Cinética , Peso Molecular , Fosforilação , ATPase Trocadora de Sódio-Potássio/isolamento & purificação , Especificidade da EspécieRESUMO
Phenytoin, a potent antiepileptic drug, has been thought to stimulate Na+, K+ transport across cell membranes, but its influence on (Na+, K+)-ATPase activity remains highly controversial. We have investigated the effects of the drug on the phosphorylation level of (Na+, K+)-ATPase partially purified from mouse, cat and human brain. (Na+, K+)-ATPase catalytic subunits [alpha(+) and alpha(-)] were resolved by sodium dodecylsulfate polyacrylamide gel electrophoresis. Previous experiments had shown that phenytoin dephosphorylates the (Na+, K+)-ATPase catalytic subunit by +/- 50% in C57/BL mice. In the present study, we showed that phenytoin (10(-4) M) decreases the phosphorylation level of (Na+, K+)-ATPase catalytic subunit by the same value in cat and human cortex. Moreover, that effect is predominant on the alpha(-) subunit, thought to be the predominant enzymatic form in non-neuronal or glial cells. The results are thus favoring the hypothesis that phenytoin stimulates the brain (Na+, K+)-ATPase. They further suggest that phenytoin mainly activates the glial enzymatic form, providing central nervous system with an enhanced ability to regulate extracellular K+.